Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps
Randomized Controlled Study of the Usage of Universal Fixed Meal Bolus Coefficients for the Control of Postprandial Hyperglycemia in the Users of Medtronic Minimed 780G Pumps
Tartu University Hospital
20 participants
Oct 10, 2023
INTERVENTIONAL
Conditions
Summary
Cross-over study of 20 pediatric patients (age 7-19) randomized to the group receiving universal fixed meal boluses coefficients (300/TDD for breakfast and 400/TDD other meal) or to the group with individualized coefficients for the period of 14 days with consecutive analysis of the results from Carelink Raport.
Eligibility
Inclusion Criteria4
- age 7-19
- type 1 diabetes diagnosed at least 1 year ago
- insulin in the dose 0,5-1,0 units/day/kg
- MiniMed 780G pump usage at least 1 month.
Exclusion Criteria3
- Active coeliac disease
- Chronic disease possible to influence diabetes treatment
- Acute disease at the moment of recruitment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Usage of universal fixed meal bolus coefficients for the control of postprandial hyperglycemia compared to individualized coefficients n the users of Medtronic Minimed 780G pumps
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06372392